AU3115000A - Megakaryocyte-induced expansion of hematopoietic stem cells - Google Patents
Megakaryocyte-induced expansion of hematopoietic stem cellsInfo
- Publication number
- AU3115000A AU3115000A AU31150/00A AU3115000A AU3115000A AU 3115000 A AU3115000 A AU 3115000A AU 31150/00 A AU31150/00 A AU 31150/00A AU 3115000 A AU3115000 A AU 3115000A AU 3115000 A AU3115000 A AU 3115000A
- Authority
- AU
- Australia
- Prior art keywords
- megakaryocyte
- stem cells
- hematopoietic stem
- induced expansion
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/145—Thrombopoietin [TPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11131398P | 1998-12-07 | 1998-12-07 | |
US60111313 | 1998-12-07 | ||
PCT/US1999/029138 WO2000034443A2 (en) | 1998-12-07 | 1999-12-07 | Megakaryocyte-induced expansion of hematopoietic stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3115000A true AU3115000A (en) | 2000-06-26 |
Family
ID=22337782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31150/00A Abandoned AU3115000A (en) | 1998-12-07 | 1999-12-07 | Megakaryocyte-induced expansion of hematopoietic stem cells |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3115000A (en) |
WO (1) | WO2000034443A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003253015A1 (en) * | 2002-06-20 | 2004-01-06 | Bionethos Holding Gmbh | Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
EP2729560A4 (en) * | 2011-07-06 | 2014-12-03 | Cellerant Therapeutics Inc | Megakaryocyte progenitor cells for production of platelets |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996000779A1 (en) * | 1994-06-28 | 1996-01-11 | Cornell Research Foundation, Inc. | Process for ex vivo expansion of hematopoietic progenitor cells |
-
1999
- 1999-12-07 WO PCT/US1999/029138 patent/WO2000034443A2/en active Application Filing
- 1999-12-07 AU AU31150/00A patent/AU3115000A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000034443A3 (en) | 2000-11-09 |
WO2000034443A2 (en) | 2000-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4336599A (en) | (in vitro) maintenance of hematopoietic stem cells | |
AU2469299A (en) | Purified populations of stem cells | |
AU2192997A (en) | Compositions and methods of making embryonic stem cells | |
AU1824600A (en) | Low oxygen culturing of cells | |
AU6869198A (en) | Universal stem cells | |
AU1119397A (en) | Ex vivo culture of stem cells | |
AU2001284160A1 (en) | Modulation of stem cell differentiation | |
AU7984498A (en) | Serum-free cell growth medium | |
AU3999499A (en) | Porous implant containing therapeutically useful compositions | |
AU6330199A (en) | Electrochemical synthesis of perfluoroalkylfluorophosphoranes | |
AU3244899A (en) | Desulfurizer and the process of making the same | |
AU9508998A (en) | Methods and compositions for binding hematopoietic stem cells | |
AU1871300A (en) | Jig assembly of optical cells | |
AU1393799A (en) | Cooling of stored water | |
IL146397A0 (en) | Ex vivo expansion of mammalian hematopoietic stem cells | |
AU6088299A (en) | Improved transformation of plastids | |
AU2832399A (en) | B cell inhibitors | |
AUPP244498A0 (en) | Keratinocyte stem cells | |
AU4214799A (en) | Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof | |
AU9732098A (en) | Hematopoietic stem cells | |
AU8808798A (en) | Method for the ex-vivo expansion of hematopoietic stem cells | |
AU5490099A (en) | Manufacture of alpha-olefins | |
AU4317597A (en) | Hematopoietic stem cells and methods for generating such cells | |
AU2001275897A1 (en) | Improvement of cell culture performance | |
AU2241699A (en) | Expression of proteolytically-sensitive peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |